N-(3-hydroxybutanoyl)homoserine lactone: structure given in first source; autoinducer required for the growth-dependent development of luminescence in Vibrio harveyi [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130846 |
| SCHEMBL ID | 4399583 |
| MeSH ID | M0172214 |
| Synonym |
|---|
| hbhsl |
| butanamide, 3-hydroxy-n-(tetrahydro-2-oxo-3-furanyl)- |
| hbhl, vibrio harveyi autoinducer |
| 126049-72-7 |
| n-(beta-hydroxybutyryl)homoserine lactone |
| n3-hbhl |
| n-(3-hydroxybutanoyl)homoserine lactone |
| SCHEMBL4399583 |
| 3-hydroxy-butanoyl-dl-homoserine lactone |
| mfcd24520804 |
| 912545-51-8 |
| 3-hydroxy-n-(2-oxooxolan-3-yl)butanimidic acid |
| DTXSID00925385 |
| 3-hydroxy-c4-homoserine lactone |
| 3-hydroxy-n-(2-oxotetrahydrofuran-3-yl)butanamide |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.75) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (11.11%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (88.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||